InvestorWire NewsRoom

Press Release

Roth Capital Partners to Host a Virtual Healthcare Private Company Forum on June 28, 2021
June 25, 2021

Roth Capital Partners to Host a Virtual Healthcare Private Company Forum on June 28, 2021

NEWPORT BEACH, Calif., June 25, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Roth Capital Partners (“Roth”),, is set to virtually present the Roth Virtual Healthcare Private Company Forum on June 28th, 2021.

This event will consist of Virtual Panels on Emerging Therapeutics and select Fireside Chats with Roth Research Analysts. This format will provide an opportunity for C-level executives representing established private healthcare companies in the Biotechnology, Pharmaceuticals and Medical Technologies verticals to tell their stories. 

“We are excited to host our Virtual Healthcare Private Company Forum for private companies. As the event continues to grow, we are bringing together a broader range of private healthcare companies, from across the US and beyond, to tell their stories,” said James Antonopoulos, Managing Director & Head of Healthcare Investment Banking at Roth. “This event is another example of Roth’s continued leadership in supporting the growth of healthcare companies, including biotechnology, specialty pharmaceuticals, medical devices & diagnostics.”

Since 2010, Roth has been involved in over 530 transactions for its Healthcare clients with a total transaction value of over $24 billion. (Source: Roth Capital Partners | 06.24.21)

For more information and event registration, please see, or contact your Roth event representative at (949) 720-5700 or [email protected].

Event Agenda (All times in ET):

MONDAY | JUNE 28, 2021 | Full details:

  8:00 am       Cullgen Inc. – Fireside Chat
  8:20 am       M6P Therapeutics – Fireside Chat
  8:40 am       Ryvu Therapeutics – Fireside Chat
  9:00 am       Novel Approaches to Tumor Eradication – Panel with Enterome & Invectys
10:00 am       Renaissance Bioscience – Fireside Chat
10:20 am       Aruna Bio – Fireside Chat
10:40 am       Dyve Biosciences – Fireside Chat
11:00 am       Next Wave of Psychedelic Drug Developers – Panel with Diamond Therapeutics, Field Trip Health (FTRP.TO), Mydecine (OTC: MYCOF) & Small Pharma (DMT.V)
12:00 pm       Natural Killer Cell Approaches to Eradicate Tumors – Panel with Alloplex Biotherapeutics, Alphageneron, Cytovia & NKGen Biotech
  1:00 pm       Active Motif – Fireside Chat
  1:20 pm       Intensity Therapeutics – Fireside Chat
  1:40 pm       Fibralign – Fireside Chat
  2:00 pm       Reva Medical – Fireside Chat

Participating Company List:

Company NameCompany Website (URL)
Active Motif
Alloplex Biotherapeutics
Aruna Bio
Cullgen Inc.
Diamond Therapeutics
Dyve Biosciences
Field Trip Health (FTRP.TO)
Intensity Therapeutics
Invectys Inc.
M6P Therapeutics
Mydecine (OTC: MYCOF)
NKGen Biotech, Inc.
Renaissance Bioscience
Reva Medical
Ryvu Therapeutics
Small Pharma (DMT.V)

Subject to Change | As of 06/22/2021

Event Media Sponsor:

Company NameCompany Website (URL)

About Roth Capital Partners, LLC:

Roth Capital Partners, LLC (“Roth”) is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, Roth provides capital raising, M&A advisory, analytical research, trading, market-making services, and corporate access. Headquartered in Newport Beach, CA, Roth is privately-held, employee owned, and maintains offices throughout the U.S. For more information on Roth, please visit

Investor Contact:
Roth Capital Partners
Isabel Mattson-Pain
Director of Marketing & Corporate Access
[email protected]

Media Contact:
InvestorBrandNetwork (IBN)
Los Angeles, California
310.299.1717 Office
[email protected]

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).